Internal Medicine, Hematology & Oncology · Peoria, IL
NPI
1174522486
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
8940 N Wood Sage Rd
Peoria, IL, 61615
Phone (309) 243-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.2M
389,074 services
Medicare patients, 2024
1,526
Average age 74
Drug cost, 2024
$5.8M
4,017 prescriptions
Company payments, 2025
$40.74
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nguyet A Le-Lindqwister was code J1439 (injection, ferric carboxymaltose, 1 mg), 43,400 times for 45 patients. In total Nguyet A Le-Lindqwister billed 389,074 services in 211 codes, and Medicare paid $5.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-03-02.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 43,400 | 45 | $0.87 | $38K |
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 34,170 | 48 | $0.26 | $9,026 |
| J9025 Injection, azacitidine, 1 mg | Office | 26,900 | 25 | $0.29 | $7,848 |
| J9267 Injection, paclitaxel, 1 mg | Office | 21,574 | 26 | $0.08 | $1,699 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 17,600 | 28 | $42.71 | $752K |
| J0185 Injection, aprepitant, 1 mg | Office | 16,120 | 52 | $1.33 | $22K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 16,060 | 170 | $0.10 | $1,578 |
| J0897 Injection, denosumab, 1 mg | Office | 13,740 | 66 | $20.55 | $282K |
| J9264 Injection, paclitaxel protein-bound particles, 1 mg | Office | 11,500 | 12 | $10.62 | $122K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 8,460 | 13 | $39.30 | $333K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 7,260 | 21 | $19.90 | $145K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 6,550 | 14 | $0.05 | $317 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 5,740 | 16 | $2.31 | $13K |
| J9022 Injection, atezolizumab, 10 mg | Office | 5,280 | 11 | $66.79 | $353K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,140 | 105 | $0.09 | $366 |
By year: 2022 $3.7M for 325,964 services; 2023 $4.1M for 322,017 services; 2024 $5.2M for 389,074 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,737 | 736 | $7.59 | $13K |
| 80053 Clinical Chemistry | 1,596 | 736 | $10.32 | $16K |
| 36415 Venipuncture Blood Collection | 1,421 | 673 | $8.64 | $12K |
| 86300 Immunoassay | 635 | 385 | $20.33 | $13K |
| 82728 Clinical Chemistry | 374 | 224 | $13.26 | $4,961 |
| 83550 Clinical Chemistry | 358 | 222 | $8.51 | $3,045 |
| 83540 Clinical Chemistry | 353 | 221 | $6.32 | $2,233 |
| 83735 Clinical Chemistry | 332 | 112 | $6.55 | $2,176 |
| 83615 Clinical Chemistry | 255 | 153 | $5.86 | $1,494 |
| 82607 Clinical Chemistry | 213 | 158 | $14.66 | $3,123 |
Medicare prescription drug claims, 2024
In 2024, the drug Nguyet A Le-Lindqwister prescribed most often to Medicare patients was Anastrozole, with 1,125 prescriptions and refills. In total Nguyet A Le-Lindqwister wrote 4,017 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 1,125 | 2,748 | 316 | $16K |
| Alendronate Sodium Generic | 212 | 505 | 53 | $2,053 |
| Ibrance Palbociclib | 205 | 205 | 22 | $2.9M |
| Dexamethasone Generic | 174 | 176 | 46 | $1,258 |
| Exemestane Generic | 158 | 334 | 48 | $26K |
| Levothyroxine Sodium Generic | 156 | 308 | 37 | $764 |
| Gabapentin Generic | 138 | 168 | 28 | $1,724 |
| Prochlorperazine Maleate Generic | 127 | 127 | 65 | $1,305 |
| Letrozole Generic | 120 | 305 | 42 | $2,107 |
| Potassium Chloride Generic | 107 | 142 | 23 | $1,368 |
| Olanzapine Generic | 101 | 101 | 32 | $243 |
| Acyclovir Generic | 72 | 104 | 19 | $702 |
| Ondansetron Hcl Generic | 72 | 72 | 24 | $1,091 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 66 | 82 | 18 | $133 |
| Eliquis Apixaban | 62 | 89 | 14 | $50K |
Brand drugs: - claims; generic drugs: 3,393 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nguyet A Le-Lindqwister $40.74 ($40.74 in general payments such as food, travel and fees) from 2 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $40.74.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $40.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.